The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs
Abstract
Natural products represent a rich reservoir of potential small chemical molecules exhibiting antiproliferation and anticancer properties. An example is berberine, a protoberberine alkaloid widely distributed in medical plants used in traditional Chinese prescriptions. Recent advances have shown that berberine exerts anticancer activities both in vitro and in vivo through different mechanisms. Berberine shows inhibitory effects on the proliferation and reproduction of certain tumorigenic microorganisms and viruses, such as Heliobacter pylori and hepatitis B virus. Transcriptional regulation of some oncogene and carcinogenesis-related gene expression and interaction with both DNA and RNA are also well documented. Besides, berberine is a broad spectrum enzyme inhibitor, which affects N-acetyltransferase, cyclooxygenase-2, and topoisomerase activities and gene/protein expression. These actions, together with the regulation of reactive oxygen species production, mitochondrial transmembrane potential, and nuclear factor-kappaB activation might underlie its antiproliferative and proapoptotic effects. More importantly, the suppression of tumor growth and metastasis, the beneficial application in combined medication, and the improvement of multidrug resistance both in vivo and in vitro clearly show its potential as an alternative medicine for tumor chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mantena, S. K., Sharma, S. D., & Katiyar, S. K. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl043 · Cited by 174
RetractedABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
Irani, K. (2000) · Circulation Research · doi:10.1161/01.res.87.3.179 · Cited by 748
Telomerase and cancer therapeutics
Harley, C. B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2275 · Cited by 728
The anti-inflammatory potential of berberine in vitro and in vivo
Kuo, C.-L., Chi, C.-W., & Liu, T.-Y. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.09.002 · Cited by 685
N-acetylation pharmacogenetics.
Weber, W. W., & Hein, D. W. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06816-4 · Cited by 648
Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Imanshahidi, M., & Hosseinzadeh, H. (2008) · Phytotherapy Research · doi:10.1002/ptr.2399 · Cited by 634
Natural products in anticancer therapy
da Rocha, A. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00063-7 · Cited by 604
Mantena, S. K., Sharma, S. D., & Katiyar, S. K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0448 · Cited by 353
Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells
Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., & Fujiwara, H. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00162-7 · Cited by 270
Cited by
Zafar, A., Khatoon, S., Khan, M. J., Abu, J., & Naeem, A. (2025) · Discover Oncology · doi:10.1007/s12672-025-02198-8 · Cited by 565
The metabolism of berberine and its contribution to the pharmacological effects
Wang, K., Feng, X., Chai, L., Cao, S., & Qiu, F. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2017.1306544 · Cited by 502
Berberine: New perspectives for old remedies
Tillhon, M., Guamán Ortiz, L. M., Lombardi, P., & Scovassi, A. I. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.018 · Cited by 477
Alkaloids Isolated from Natural Herbs as the Anticancer Agents
Lu, J.-J., Bao, J.-L., Chen, X.-P., Huang, M., & Wang, Y.-T. (2012) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2012/485042 · Cited by 384
Self-citationZou, K., Li, Z., Zhang, Y., Zhang, H.-Y., Li, B., Zhu, W.-L., Shi, J.-Y., Jia, Q., & Li, Y.-M. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.125 · Cited by 317
Berberine: a potential phytochemical with multispectrum therapeutic activities
Vuddanda, P. R., Chakraborty, S., & Singh, S. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.517745 · Cited by 316
Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis
Gali-Muhtasib, H., Hmadi, R., Kareh, M., Tohme, R., & Darwiche, N. (2015) · Apoptosis · doi:10.1007/s10495-015-1169-2 · Cited by 293
Xuan, J., Zeng, T., Feng, Z., Deng, Q., Chen, J., Lu, L., Xiao, W., & Alper, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201409999 · Cited by 283
The Anticancer Properties of Salvia Miltiorrhiza Bunge (Danshen): A Systematic Review
Chen, X., Guo, J., Bao, J., Lu, J., & Wang, Y. (2014) · Medicinal Research Reviews · doi:10.1002/med.21304 · Cited by 279
Self-citationRescifina, A., Zagni, C., Varrica, M. G., Pistarà, V., & Corsaro, A. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.029 · Cited by 274
Multi-Target Drugs: The Trend of Drug Research and Development
Lu, J.-J., Pan, W., Hu, Y.-J., & Wang, Y.-T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040262 · Cited by 259
Self-citationLo, T.-F., Tsai, W.-C., & Chen, S.-T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075628 · Cited by 122
Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
Zhang, C., Sheng, J., Li, G., Zhao, L., Wang, Y., Yang, W., Yao, X., Sun, L., Zhang, Z., & Cui, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01461 · Cited by 102
Self-citationAn Overview of Potential Natural Photosensitizers in Cancer Photodynamic Therapy
Aziz, B., Aziz, I., Khurshid, A., Raoufi, E., Esfahani, F. N., Jalilian, Z., Mozafari, M. R., Taghavi, E., & Ikram, M. (2023) · Biomedicines · doi:10.3390/biomedicines11010224 · Cited by 70
Metadata
- Authors
- Sun, Y., Xun, K., Wang, Y., & Chen, X.
- Venue
- Anti-Cancer Drugs
- Published
- 2009-10
- Volume
- 20
- Issue
- 9
- Pages
- 757-769
- ISSN
- 0959-4973 (ISSN-L)
- OpenAlex
- W2171918265
- Cited by
- 417
- References
- 111
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.